Eton Pharmaceuticals Relaunches HEMANGEOL (Propranolol) Oral Solution
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Anovo Specialty Pharmacy distribution and Eton Cares support, improving access to the only FDA-approved treatment for infantile hemangioma.
Eton Pharmaceuticals | 05/05/2026 | By News Bureau
Eton Pharmaceuticals Introduces Galzin Capsules for Wilson Disease
Galzin is FDA-approved for the maintenance treatment of patients with Wilson disease who have been initially treated with a chelating agent.
Eton Pharmaceuticals | 04/03/2025 | By Aishwarya | 357
Eton Pharmaceuticals Announces Acquisition of Galzin
Galzin is FDA-approved as a maintenance treatment of patients with Wilson Disease who have been initially treated with a chelating agent.
Eton Pharmaceuticals | 04/01/2025 | By Aishwarya | 295
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy